Trial intelligence / Profile preview

Neoadjuvant Chemotherapy Regimens in Advanced Nasopharyngeal Carcinoma

NCT02500940Phase 3Unknown

Sponsor
Taichung Veterans General Hospital
Start
May 2015
Primary completion
May 2016
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of folinic acid in nasopharyngeal carcinoma (NPC), sponsored by Taichung Veterans General Hospital. Status: unknown.

02

Drugs

folinic acid
03

Conditions

nasopharyngeal carcinoma (NPC)

Beyond the preview

Go deeper on NCT02500940.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02500940.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call